Detalhe da pesquisa
1.
The Role of the Neurological Examination in Primary Care Referrals to Neurology.
Can J Neurol Sci
; 50(6): 922-924, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36321544
2.
Practice Guidelines for Canadian Neurophysiology Laboratories During the COVID-19 Pandemic.
Can J Neurol Sci
; 48(1): 25-30, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32811585
3.
The neurologist's role in disabling multiple sclerosis: A qualitative study of patient and care provider perspectives.
Mult Scler
; 26(7): 837-842, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31074683
4.
Risk of secondary progressive multiple sclerosis: A longitudinal study.
Mult Scler
; 26(1): 79-90, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31397221
5.
A Diverse Specialty: What Students Teach Us About Neurology and "Neurophobia".
Can J Neurol Sci
; 47(5): 675-680, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32450930
6.
Applying a Stepped-Care Framework for Functional Neurological Disorder Management.
Can J Neurol Sci
; : 1-3, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38425193
7.
Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.
Brain
; 140(9): 2426-2443, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29050389
8.
Empower Your Applicants: Why Residency Programs Need to up Their Website Game.
Can J Neurol Sci
; : 1-2, 2023 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37614128
9.
Temporary Adaptations or New (Virtual) Reality? Applying to Residency During a Pandemic.
Can J Neurol Sci
; 50(2): 163-164, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35272732
10.
Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice.
Mult Scler
; 23(10): 1346-1357, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27885062
11.
Contribution of different relapse phenotypes to disability in multiple sclerosis.
Mult Scler
; 23(2): 266-276, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27055805
12.
Defining secondary progressive multiple sclerosis.
Brain
; 139(Pt 9): 2395-405, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27401521
13.
The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis.
Mult Scler
; 22(4): 520-32, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26199347
14.
The Under-Utilization of the Head Impulse Test in the Emergency Department.
Can J Neurol Sci
; 43(3): 398-401, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26787132
15.
Don't Make the Best of It, Make It Better: Matching to Residency Programs During COVID-19.
Can J Neurol Sci
; 48(1): 3-4, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33077006
16.
General Practitioner Preferences in Managing Care of Multiple Sclerosis Patients.
Can J Neurol Sci
; 43(1): 142-8, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26132320
17.
Response from Authors to the Letter to the Editor.
Can J Neurol Sci
; 48(1): 135-137, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054869
18.
Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.
Ann Neurol
; 76(6): 880-90, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25283272
19.
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis.
Mult Scler
; 21(9): 1159-71, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25480857
20.
Two Multiple Sclerosis Quality-of-Life Measures: Comparison in a National Sample.
Can J Neurol Sci
; 42(1): 55-63, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25586701